<DOC>
	<DOCNO>NCT02352779</DOCNO>
	<brief_summary>This randomize pilot clinical trial study omega-3 fatty acid reduce cancer-related fatigue breast cancer survivor . Supplementation omega-3 fatty acid may help reduce cancer-related fatigue breast cancer survivor .</brief_summary>
	<brief_title>Omega-3 Fatty Acid Reducing Cancer-Related Fatigue Breast Cancer Survivors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To collect preliminary statistical data ( mean change standard deviation ) two omega-3 supplementation ( omega-3 fatty acid ) regimens ( 1.65 g/day 3.3 g/day ) compare placebo reduce cancer-related fatigue ( CRF ) fatigue breast cancer survivor . SECONDARY OBJECTIVES : I . To determine adherence adverse event two omega-3 supplementation regimen ( 1.65 g/day 3.3 g/day ) compare placebo . II . To collect preliminary statistical data ( mean change standard deviation ) two omega-3 supplementation regimen ( 1.65 g/day 3.3 g/day ) compare placebo reduce inflammation ( C-reactive protein [ CRP ] , interleukin 6 [ IL-6 ] , tumor necrosis factor [ TNF ] -alpha ) fatigue breast cancer survivor . TERTIARY OBJECTIVES : I . To explore effect two omega-3 supplement regimens serum fatty acid level compare placebo . OUTLINE : Patients randomize 1 3 arm . ARM I : Patients receive low-dose omega-3 fatty acid supplementation orally ( PO ) twice daily ( BID ) placebo PO BID 6 week . ARM II : Patients receive high-dose omega-3 fatty acid supplementation PO BID 6 week . ARM III : Patients receive placebo PO BID 6 week .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Have confirm diagnosis breast cancer ; participant one primary cancer diagnosis past Have undergone type combination standard adjuvant treatment ( surgery , chemotherapy , radiation therapy ) breast cancer Have complete form standard adjuvant treatment ( surgery , chemotherapy , radiation therapy ) breast cancer 4 36 month prior enrollment study ; participant currently take hormone ( tamoxifen ) monoclonal antibody ( Herceptin ) Must cancerrelated fatigue , indicate response 4 great ask rate level fatigue bad past week 11point scale anchor `` 0 '' = fatigue `` 10 '' = bad imagine Be able read English Able swallow medication Give write informed consent Have use marine omega3 supplement time within previous 3 month ( include prescription omega3 drug LovazaÂ® ) Be take anticoagulant medication ( include aspirin ) Have sensitivity allergy fish and/or shellfish Have sensitivity allergy soy and/or soybean Have confirm diagnosis chronic fatigue syndrome diagnosis know cause severe fatigue</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cancer Survivor</keyword>
</DOC>